8,087 results on '"Arthritis, Psoriatic"'
Search Results
102. 2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis (PROMPT)
103. A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment
104. A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis (U-POPS)
105. Monitoring of Inflammatory Conditions
106. Follow-up Evaluating Clinical and Radiological Outcomes of Total Shoulder Arthroplasty With Permedica's MIRAI Prosthesis
107. Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication (Nor-vaC)
108. Effect of Silymarin Against Methotrexate-induced Liver Injury in Rheumatic Diseases
109. Quantitative Ultrasound of the Enthesis in Fibromyalgia and Psoriatic Arthritis
110. A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic Arthritis
111. A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis
112. Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.
113. Influence of Sodium Intake in spondyLoarthriTes (SALT)
114. Psoriatic Arthritis Research Collaborative: Biologic Sub-Study (PARC-B)
115. Psoriatic Arthritis D2P Screening
116. Effect of Metformin on Carotid Atherosclerosis for Non-diabetic Patients With PsA (CAMPA Study)
117. Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.
118. Psoriatic Arthritis and Psoriasis Treatment Decision Aid (DA)
119. GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA (GOLMEPsA) (GOLMePsA)
120. Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis
121. Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases
122. VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)
123. A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis (BE VIVID)
124. Arthroscopic Synovectomy of the Wrist in Inflammatory Arthritis (ARCTIC)
125. Rheumatology Patient Registry and Biorepository
126. A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis (BE READY)
127. Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases (FRONT)
128. Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis. (FOREMOST)
129. Small Changes Behavioural Weight Loss Treatment Approach for Psoriatic Arthritis Patients With Comorbid Obesity
130. PatientSpot Formerly Known as ArthritisPower
131. Bioequivalence Study of Two Products of Apremilast 30 mg Tablets in Healthy, Adult, Human Subjects
132. The Effect of Ketogenic Diet Versus Mediterranean Diet in Patients With Obesity and Psoriatic Arthritis
133. Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK Registry
134. Impact of Hyperuricemia on Psoriatic Arthritis (Psoriatic)
135. A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Active Psoriatic Arthritis
136. A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis (BE ACTIVE 2)
137. Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial (SPEED)
138. Biobank for Inflammatory Chronic Diseases and Osteoporosis (BIOTOUL)
139. Multicentre ObservatioNal Initiative in Treat to Target Outcomes in Psoriatic Arthritis (MONITOR)
140. Response to Upadacitinib of Enthesitis Evaluated by Ultrasound in Patients With Psoriatic Arthritis
141. APACHE Cohort (A Psoriatic Arthritis CoHort) (APACHE)
142. A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD) (SELECT - PsA 1)
143. COVID-19 VaccinE Response in Rheumatology Patients (COVER)
144. From Psoriasis to Psoriatic Arthritis: Ultrasound Insights Connecting Psoriasis with Subclinical Musculoskeletal Inflammation and the Path to Psoriatic Arthritis.
145. Treatment Persistence and Switching Patterns of Adalimumab Biosimilar ABP 501 in European Patients with Rheumatologic Diseases.
146. A Randomized, Open, Parallel, Controlled, Multi-center, Interventional, Cross-sectional Study to Evaluate the Detection Rate of Psoriatic Arthritis in Korean Moderate-to-severe Psoriasis Patients, With or Without Active Screening for Arthritis in Psoriasis (ASAP Study) (ASAP)
147. Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis
148. A Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands (REWARD)
149. Cohort Project of Patients With Inflammatory Rheumatism (SMAP)
150. Treatment Goals in Psoriatic Arthritis (PaGoPsA)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.